Stoboclo Injection
Product Images NDC 72606-037

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Stoboclo (NDC 72606-037). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Celltrion Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (Stoboclo 01)

An instructional diagram showing the components of a Stoboclo (denosumab-bmwo) 60 mg/mL subcutaneous injection syringe before and after use. Key parts labeled include the plunger rod, finger flange, viewing window, safety guard, needle, medicine, and cap. The diagram contrasts the syringe filled with medicine before use and empty with needle retracted after use.*

FDA Label Image

Image (Stoboclo 02)

An instructional illustration showing a person holding a pre-filled syringe of Stoboclo (denosumab-bmwo) injection. The image demonstrates the removal of the needle cover by pulling it straight off, with an inset depicting the proper disposal of the cover into a sharps container.*

FDA Label Image

Image (Stoboclo 03)

An illustration showing recommended subcutaneous injection sites on a human body. Shaded areas include the upper arms, abdomen (excluding a central circular area), and the front thighs.*

FDA Label Image

Image (Stoboclo 04)

Illustration showing the use of a Stoboclo injection device for subcutaneous administration. The image depicts a hand holding the injection device at the injection site, with a close-up highlighting the device details and proper positioning for injection.*

FDA Label Image

Image (Stoboclo 05)

An instructional illustration showing a hand holding a syringe poised for subcutaneous injection into a bent arm. The syringe is equipped with a needle and a safety shield, with an arrow indicating the injection site on the arm.*

FDA Label Image

Chemical Structure (Stoboclo 06)

A line graph showing patient hip fracture incidence (%) over 36 study months, comparing denosumab (solid line) versus placebo (dashed line). The graph plots hip fracture incidence on the Y-axis and study months on the X-axis, indicating lower incidence in the denosumab group compared to placebo over time.*

FDA Label Image

Principal Display Panel (60 mg/mL Syringe Carton)

Carton label for Stoboclo injection, denosumab-bmwo 60 mg/mL, a single-dose prefilled syringe for subcutaneous use. The label states it is for administration by a healthcare provider and highlights the inclusion of a Medication Guide. It is manufactured by CELLTRION, Inc. and distributed by CELLTRION USA, Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.